TWA
ALXN

TCI Wealth Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

TCI Wealth Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-155
Closed -$28K – 2679
2021
Q2 		$28K Buy
155
+22
+17% +$3.78K ﹤0.01% 531
2021
Q1 		$20K Buy
133
+76
+133% +$11.8K 0.01% 583
2020
Q4 		$9K Buy
57
+3
+6% +$386 ﹤0.01% 697
2020
Q3 		$6K Buy
54
+4
+8% +$432 ﹤0.01% 742
2020
Q2 		$6K Hold
50
– – ﹤0.01% 714
2020
Q1 		$4K Sell
50
-343
-87% -$33.7K ﹤0.01% 815
2019
Q4 		$43K Buy
393
+343
+686% +$36.7K 0.02% 416
2019
Q3 		$5K Hold
50
– – ﹤0.01% 835
2019
Q2 		$7K Hold
50
– – ﹤0.01% 711
2019
Q1 		$7K Hold
50
– – ﹤0.01% 722
2018
Q4 		$5K Hold
50
– – ﹤0.01% 793
2018
Q3 		$7K Sell
50
-73
-59% -$9.16K ﹤0.01% 727
2018
Q2 		$15K Sell
123
-130
-51% -$15.2K 0.01% 561
2018
Q1 		$28K Sell
253
-10
-4% -$1.2K 0.01% 425
2017
Q4 		$31K Hold
263
– – 0.01% 415
2017
Q3 		$37K Sell
263
-49
-16% -$6.66K 0.02% 358
2017
Q2 		$38K Buy
312
+49
+19% +$5.7K 0.02% 360
2017
Q1 		$32K Buy
263
+10
+4% +$1.29K 0.02% 367
2016
Q4 		$31K Sell
253
-10
-4% -$1.22K 0.02% 408
2016
Q3 		$32K Hold
263
– – 0.02% 359
2016
Q2 		$31K Hold
263
– – 0.02% 355
2016
Q1 		$37K Sell
263
-77
-23% -$11.3K 0.02% 342
2015
Q4 		$65K Buy
+340
New +$59.4K 0.04% 263
2015
Q1 		– Sell
-13
Closed -$2K – 984
2014
Q4 		$2K Buy
+13
New +$2.41K ﹤0.01% 766
2014
Q2 		– Sell
-9
Closed -$1K – 942
2014
Q1 		$1K Sell
9
-32
-78% -$5.09K ﹤0.01% 839
2013
Q4 		$5K Buy
+41
New +$4.92K ﹤0.01% 569

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

TCI Wealth Advisors's ALXN Position: Q3 2021 in Review

TCI Wealth Advisors sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 155 shares — an estimated $28K sold.

TCI Wealth Advisors first reported a position in ALXN in Q4 2013 and held it in 26 quarters. The position peaked at $65K in Q4 2015. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • TCI Wealth Advisors reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • TCI Wealth Advisors sold 155 Alexion Pharmaceuticals shares in Q3 2021, an estimated $28K.
  • TCI Wealth Advisors first reported a position in Alexion Pharmaceuticals in Q4 2013 and held it in 26 quarters.
  • TCI Wealth Advisors's Alexion Pharmaceuticals position peaked at $65K in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on TCI Wealth Advisors's 13F filing for Q3 2021, filed 29 Oct 2021.